pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAF(II)250 mutants

Genes and Development

Volumn 12, Issue 8, 1998, Pages 1217-1226

  Haviv, Izhak ^a   Matza, Yehuda ^a   Shaul, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apoptosis; BHK ts cells; Cell cycle; HBxAg; TAF independent transcription; Transcription coactivation

Indexed keywords

APOPTOSIS; ARTICLE; CELL GROWTH; HEPATITIS B VIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TEMPERATURE SENSITIVE MUTANT; TRANSCRIPTION REGULATION;

HEPATITIS B VIRUS; PAPOVAVIRIDAE; RNA VIRUSES;

EID: 0032522825     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.8.1217     Document Type: Article

References (53)

1. Benn, J. and R.J, Schneider. 1994. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc. Natl. Acad. Sci. 91: 10350-10354.
2. Boyer, T.G. and A.J. Berk. 1993. Functional interaction of adenovirus E1A with holo-TFIID. Genes & Dev. 7: 1810-1823.
3. Bryant, G.O., L.S. Martel, S.K. Burley, and A.J. Berk. 1996. Radical mutations reveal TATA-box binding protein surfaces required for activated transcription in vivo. Genes & Dev. 10: 2491-2504.
4. Cairns, B.R., N.L. Henry, and R.D. Kornberg. 1996. TFG/ TAF30/ANC1, a component of the yeast SWI/SNF complex that is similar to the leukemogenic proteins ENL and AF-9. Mol. Cell. Biol. 16: 3308-3316.
5. Carrozza, M.J. and N.A. DeLuca. 1996. Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol. Cell Biol. 16: 3085-3093.
6. Chen, H.S., S. Kaneko, R. Girones, R.W. Anderson, W.E. Hornbuckle, B.C. Tennant, P.J. Cote, J.L. Gerin, R.H. Purcell, and R.H. Miller. 1993. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67: 1218-1226.
7. Chen, J.L., L.D. Attardi, C.P. Verrijzer, K. Yokomori, and R. Tjian. 1994. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell 79: 93-105.
8. Cheong, J., M. Yi, Y. Lin, and S. Murakami. 1995. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J. 14: 143-150.
9. Colgrove, R., G. Simon, and D. Ganem. 1989. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J. Virol 63: 4019-4026.
10. Cross, J.C., P. Wen, and W.J. Rutter. 1993. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc. Natl. Acad. Sci. 90: 8078-8082.
11. Damania, B. and J.C. Alwine. 1996. TAF-like function of SV40 large T antigen. Genes & Dev. 10: 1369-1381.
12. De-Medina, T. and Y. Shaul. 1994. Functional and structural similarity between the X protein of hepatitis B virus and nucleoside diphosphate kinases. FEBS Lett. 351: 423-426.
13. Dubrovskaya, V., A.C. Lavigne, I. Davidson, J. Acker, A. Staub, and L. Tora. 1996. Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex. EMBO J. 15: 3702-3712.
14. Dynlacht, B.D., T. Hoey, and R. Tjian. 1991. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell 66: 563-576.
15. Faktor, O. and Y. Shaul. 1990. The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax. Oncogene 5: 867-872.
16. Farmer, G., J. Bargonetti, H. Zhu, P. Friedman, R. Prywes, and C. Prives. 1996. Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo. Mol. Cell. Biol. 16: 4295-4304.
17. Feitelson, M.A., M. Zhu, L.X. Duan, and W.T. London. 1993. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8: 1109-1117.
18. Goodrich, J.A., T. Hoey, C.J. Thut, A. Admon, and R. Tjian. 1993. Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell 75: 519-550.
19. Haviv, I., D. Vaizel, and Y. Shaul. 1995. The X protein of hepatitis B virus coactivates potent activation domains. Mol. Cell. Biol. 15: 1079-1085.
20. _. 1996. pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J. 15: 3413-3420.
21. Haviv, I., M. Shamay, and Y. Shaul. 1998. Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol. Cell. Biol. (in press).
22. 1 mutants of the BHK21 cell line derived from golden hamster. Gene 141: 267-270.
23. Henry, N.L., A.M. Campbell, W.J. Feaver, D. Poon, P.A. Weil, and R.D. Kornberg. 1994. TFIIF-TAF-RNA polymerase II connection. Genes & Dev. 8: 2868-2878.
24. Hori, R., S. Pyo, and M. Carey. 1995. Protease footprinting reveals a surface on transcription factor TFIIB that serves as an interface for activators and coactivators. Proc. Natl. Acad. Sci. 92: 6047-6051.
25. Kekule, A.S., U. Lauer, L. Weiss, B. Luber, and P.H. Hofschneider. 1993. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway (see comments). Nature 361: 742-725.
26. Lin, Y., T. Nomura, J. Cheong, D. Dorjsuren, K. Iida, and S. Murakami. 1997. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J. Biol. Chem. 272: 7132-7139.
27. Maguire, H.F., J.P. Hoeffler, and A. Siddiqui. 1991. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252: 842-844.
28. Martin, K.J., J.W. Lillie, and M.R. Green. 1990. Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets. Nature 346: 147-152.
29. Mazzarelli, J.M., G.B. Atkins, J.V. Geisberg, and R.P. Ricciardi. 1995. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110. Oncogene 11: 1859-1864.
30. Murakami, S., J. Cheong, S. Ohno, K. Matsushima, and S. Kaneko. 1994. Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology 199: 243-246.
31. Natoli, G., M.L. Avantaggiati, P. Chirillo, P.L. Puri, A. Ianni, C. Balsano, and M. Levrero. 1994. Ras-and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 9: 2837-2843.
32. Parvin, J.D., H.T. Timmcrs, and P.A. Sharp. 1992. Promoter specificity of basal transcription factors. Cell 68: 1135-1144.
33. Qadri, I., H.F. Maguire, and A. Siddiqui. 1995. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc. Natl. Acad. Sci. 92: 1003-1007.
34. Qadri, I., M.E. Ferrari, and A. Siddiqui. 1996. The hepatitis B virus transactivator protein, HBx, interacts with single-stranded DNA (ssDNA). Biochemical characterizations of the HBx-ssDNA interactions. J. Biol Chem.271: 15443-15450.
35. Resnitzky, D. and S.I. Reed. 1995. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15: 3463-3469.
36. Runkel, L., M. Fischer, and H. Schaller. 1993. Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function. Virology 197: 529-536.
37. Ruppert, S. and R. Tjian. 1995. Human TAFII250 interacts with RAP74: Implications for RNA polymerase II initiation. Genes & Dev. 9: 2747-2755.
38. Sekiguchi, T., Y. Nohiro, Y. Nakamura, N. Hisamoto, and T. Nishimoto. 1991. The human CCG1 gene, essential for progression of the G1 phase, encodes a 210-kilodalton nuclear DNA-binding protein. Mol Cell. Biol 11: 3317-3325.
39. Sekiguchi, T. , T. Nakashima, T. Hayashida, A. Kuraoka, S. Hashimoto, N. Tsuchida, Y. Shibata,T. Hunter, and T. Nishimoto. 1995. Apoptosis is induced in BHK cells by the tsBN462/13 mutation in the CCG1/TAFII250 subunit of the TFIID basal transcription factor. Exp. Cell Res. 218: 490-498.
40. Shaul, Y. 1991. Regulation of HBV Transcription. In Molecular biology of the hepatitis B virus (ed. A. McLachlan), pp. 193-212. CRC Press, Boca Raton, FL.
41. Talavera, A. and C. Basilico. 1977. Temperature sensitive mutants of BHK cells affected in cell cycle progression. J. Cell Physiol. 92: 425-436.
42. Tansey, W.P. and W. Herr. 1995. The ability to associate with activation domains in vitro is not required for the TATA box-binding protein to support activated transcription in vivo. Proc. Natl. Acad. Sci. 92: 10550-10554.
43. Tansey, W.P., S. Ruppert, R. Tjian, and W. Herr. 1994. Multiple regions of TBP participate in the response to transcriptional activators in vivo. Genes & Dev. 8: 2756-2769.
44. Tong, X., F. Wang, C.J. Thut, and E. Kieff. 1995. The EpsteinBarr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. J. Virol. 69: 585-588.
45. Truant, R., J. Antunovic, J. Greenblatt, C. Prives, and J.A. Cromlish. 1995. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J. Virol. 69: 1851-1859.
46. Tyree, C.M., C.P. George, D.L. Lira, S.L. Wampler, M.E. Dahmus, L. Zawel, and J.T. Kadonaga. 1993. Identification of a minimal set of proteins that is sufficient for accurate initiation of transcription by RNA polymerase II. Genes & Dev. 7: 1254-1265.
47. Unger, T. and Y. Shaul. 1990. The X protein of the hepatitis B virus acts as a transcription factor when targeted to its responsive element. EMBO J. 9: 1889-1895.
48. Wang, E.H. and R. Tjian. 1994. Promoter-selective transcriptional defect in cell cycle mutant ts13 rescued by hTAFII250. Science 263: 811-814.
49. Wang, X.W., K. Forrester, H. Yeh, M.A. Feitelson, J.R. Gu, and C.C. Harris. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. 91: 2230-2234.
50. Wei, Y., G. Fourel, A. Ponzetto, M. Silvestro, P. Tiollais, and M.A. Buendia. 1992. Hepadnavirus integration: Mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors. J. Virol. 66: 5265-5276.
51. Zhou, Q. and P.A. Sharp. 1995. Novel mechanism and factor for regulation by HIV-1 Tat. EMBO J. 14: 321-328.
52. Zhou, Q., P.M. Lieberman, T.G. Boyer, and A.J. Berk. 1992. Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter. Genes & Dev. 6: 1964-1974.
53. Zoulim, F., J. Saputelli, and C. Seeger. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68: 2026-2030.